Alzheimer's Disease Trial, Recruiting NCT05893524 Sponsor: Dalarna University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05893524
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a patient currently having your memory assessed at Uppsala University Hospital in Sweden
  • You are a patient currently having your memory assessed at Falu Hospital in Sweden
  • You have normal cognitive (thinking and memory) function, shown by scoring above 26 on a standard memory test called the MMSE

Who may not be able to join:

  • You are unable to walk three metres back and forth
  • You are unable to stand up from a seated position on your own
  • You use a walking aid (such as a walker or crutches) indoors
  • You are currently in hospital or have been hospitalised in the last 2 weeks
  • You need an interpreter to communicate in Swedish

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anna Cristina Åberg, PhD, Dalarna University

Phone: +4623778082

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dalarna University
Registry
ClinicalTrials.gov
Start date
9 April 2015
Est. completion
24 December 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Conversion to dementia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov